Abbott Laboratories has seen its stock price drop to $87. 54, a level not seen in over a year. This decline comes despite the company bringing in $44. 3 billion in revenue last year and posting $11. 16 billion in sales for the first quarter of 2026—a 7. 8% increase from the same period the year befo
Earth Science Tech Inc. is making waves in the healthcare industry. This company is not just about owning assets. It's about actively managing them. They focus on healthcare markets. They prioritize compliance and scaling. They want to build lasting value, not just quick profits. The company has a
Montana's health care marketplace is shutting down this week. This move comes as premiums remain high, leaving many people wondering what happens next. The state's senators, Steve Daines and Tim Sheehy, back a Republican plan. They want federal money to go towards health savings accounts instead of
A new drug called Amvuttra is making waves in the UK. It's designed to help people with a rare heart condition called ATTR-CM. This condition happens when faulty proteins build up in the heart, which can make it hard for the heart to work properly. The drug is already approved for this use, as well
Veterans have a new option for health coverage. These are called Veteran Medicare Advantage affinity plans, or VMAPs. They are designed to attract veterans, including those who already have the Veterans Health Administration (VHA) coverage. This is a big change. Before this, there wasn't much in
Biosimilars are like generic versions of biologic drugs. They are almost identical to the original biologic drug, known as the reference product. The first biosimilar hit the market in 2006. Since then, the path to creating and using biosimilars has faced many hurdles. These challenges can lead to p
